NCT05095896View on ClinicalTrials.gov

The Serum Lipid Profiles in ITP: a Retrospective Study

CompletedOBSERVATIONAL
Enrollment

457

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Immune Thrombocytopenia
Interventions
OTHER

ITP patients

ITP patients were enrolled in this study based on Chinese consensus of ITP.12 Patients were excluded as (1) receiving platelet transfusion within 7 days or ITP-related medication within 3 months (2) treated with lipid-lowing agents, including statins, fibrates, niacin, bile sequestrant resins, ezetimibe and so on.

Trial Locations (1)

273300

Qilu hospital of Shandong university, Jinan

All Listed Sponsors
lead

Ming Hou

OTHER

NCT05095896 - The Serum Lipid Profiles in ITP: a Retrospective Study | Biotech Hunter | Biotech Hunter